Skip to content
  • About
  • Board
  • News
  • Sign Up
  • Contact

Visit

vjhemonc logo
VJOncology
Logo
  • Home (current)
  • Diseases
    Genitourinary
    Lung
    Head and Neck
    Breast
    Gynecological
    Skin
    View all Diseases
    • Topics
      Treatment
      Early Diagnosis
      Nursing
      Pharmacy
      Supportive Care
      Policy
      View all Topics
      • Conferences
        NCRI
        2019
        ISOPP
        2019
        ESMO
        2019
        EONS
        2019
        ASCO
        2019
        ELCC
        2019
        View all Conferences
        • Features
        • Podcasts
          • About
          • Board
          • News
          • Sign Up
          • Contact

        adverse events

        2:19
        Can spinners improve understanding of adverse events in patients with cancer?
        Lisa Holle
        2:33
        irAEs with single-agent PD-1 vs PD-L1 inhibitors
        Petros Grivas
        4:14
        Evaluation of costs associated with AEs in urothelial cancer patients
        Petros Grivas
        1:30
        AdRad safety results: radium-233/VMAT RT in the first-line for metastatic prostate cancer
        Joe O'Sullivan
        1:46
        Adverse events in bladder cancer immunotherapy
        Jonathan Rosenberg
        1:41
        Avoiding chemotherapy in the treatment of breast cancer
        Peter Fasching
        1:10
        Optimizing treatment for renal cell carcinoma with sequential therapies
        Robert Figlin
        2:19
        Chemotherapy vs. immunotherapy for the treatment of Merkel cell carcinoma
        Paul Nghiem
        3:08
        Improved survival, toxicity & QoL with pembrolizumab in head and neck cancer
        Kevin Harrington
        3:39
        VXM01 vaccine in progressive glioblastoma: final results
        Wolfgang Wick
        0:54
        Can checkpoint inhibitors combinations replace single agent drugs?
        Christopher Campen
        1:03
        Guiding clinicians to recognize toxicity levels of newer immunotherapy agents
        Christopher Campen
        1:58
        Managing the adverse events of immune checkpoint inhibitors
        Christopher Campen
        3:07
        Vinflunine shows a chemotherapeutic advantage for locally-advanced and metastatic penile cancer
        Lisa Pickering
        2:13
        Head-to-head: tolerability of enzalutamide vs. abiraterone acetate for metastatic CRPC
        Neal Shore
        1:31
        The nurse’s perspective on caring for lung cancer patients receiving immunotherapy
        Rachel Thomas
        • 1
        • 2
        • Next
        vjoncology logo VJOncology is intended for Healthcare Professionals only

        By choosing to continue, you are confirming that you are a healthcare professional

        VJO needs the contact information you provide to inform you about our latest oncology news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

        Please enter your details if you would like to receive the latest oncology news and updates

        Continue
        Disease channels
        • Genitourinary
        • Lung
        • Head and Neck
        • Breast
        • Gynecological
        • Skin
        • View all
        Join our community

        Keep up-to-date via social media

        Sign up for email updates

        Get great new content delivered to your inbox

        Sign up
        mmp logo

        Magdalen Centre
        The Oxford Science Park
        Oxford OX4 4GA, United Kingdom

        VJOncology logo
        The content of VJOncology is intended for healthcare professionals
        • Cookie Policy
        • Privacy Policy
        • Terms of Use
        • Editorial Policy